Yahoo Malaysia Web Search

Search results

  1. Aug 27, 2023 · ARREST is the first and only randomised trial of delivery to a cardiac arrest centre following resuscitated OHCA in the community. The success of this trial is attributable to the research infrastructure at the London Ambulance Service and the pan-London cardiac network, which facilitated the success of a trial of this scale and complexity.

  2. Nov 13, 2020 · To our knowledge, the ARREST trial is the first randomised interventional trial to assess the effect of early ECMO-facilitated resuscitation compared with standard ACLS treatment for survival of patients with out-of-hospital refractory cardiac arrest.

  3. www.thebottomline.org.uk › summaries › icmARREST – The Bottom Line

    Nov 20, 2020 · Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. D Yannopoulos et al.

  4. Dec 5, 2020 · The ARREST trial is registered with ClinicalTrials.gov, NCT03880565 . Findings: Between Aug 8, 2019, and June 14, 2020, 36 patients were assessed for inclusion. After exclusion of six patients, 30 were randomly assigned to standard ACLS treatment (n=15) or to early ECMO-facilitated resuscitation (n=15).

  5. Nov 13, 2020 · We read with interest about the outcomes of advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation in the ARREST trial. 1

  6. Aug 23, 2023 · Researchers out of the UK randomly assigned 862 patients (32% women), who were resuscitated following OHCA and who did not show signs of ST-elevation on their post-resuscitation electrocardiogram (ECG), to one of seven cardiac arrest centers in London (n=431) or the geographically closest emergency department at one of 32 hospitals in the city ...

  7. Nov 13, 2020 · The ARREST trial showed that ECMO was superior to standard ACLS at improving survival to hospital discharge. Description: The goal of the trial was to evaluate extracorporeal membrane oxygenation (ECMO) initiated in the catheterization laboratory compared with standard advanced cardiac life support (ACLS) among patients with out-of-hospital ...